Abstract
The characteristics of ascites in patients with POEMS syndrome, which comprise polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes, are unknown. We described the frequency of ascites at presentation of POEMS syndrome and further evaluated for the pathogenesis and nature of the ascites. One hundred and six consecutive patients with POEMS syndrome in Chinese PLA General Hospital were evaluated for the presence of ascites, and the cellular and biochemical characteristics of the ascitic fluids were assessed. Serum levels of complement, cytokines, and clinical chemistry parameters were analyzed in peripheral blood samples of the patients with POEMS syndrome. Ascites was observed in 42 of 106 (39.6 %) patients with POEMS syndrome. Patients with ascites had significantly high serum levels of C3 and C4 complement components and TNF-α (all p < 0.01). In 31 (73.8 %) patients who underwent paracentesis, the ascitic fluids had low serum ascites albumin gradients (SAAG), indicating non-portal hypertension. Spontaneous bacterial peritonitis was not observed. Ascites is a common complication of POEMS syndrome and has characteristics of non-portal hypertension, based on low SAAG. Increased immune activation and inflammatory status could contribute to the pathogenesis of ascites in POEMS syndrome.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E et al (1984) The Crow–Fukase syndrome: a study of 102 cases in Japan. Neurology 34:712–720
Cui RT, Huang XS, Shi Q, Tian CL, Liu JX, Pu CQ (2011) POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes) syndrome in China. Intern Med J 41:481–485
Bardwick PA, Zveifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL (1980) Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes: the POEMS syndrome. Medicine 59:311–322
Dispenzieri A (2012) POEMS syndrome: update on diagnosis, risk-stratification, and management. Am J Hematol 87:804–814
Singh D, Wadhwa J, Kumar L, Raina V, Agarwal A, Kochupillai V (2003) POEMS syndrome: experience with fourteen cases. Leuk Lymphoma 44:1749–1752
Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR et al (2003) POEMS syndrome: definitions and long-term outcome. Blood 101:2496–2506
Higuchi M, Kamijo H, Koyama T, Kaneko Y, Kamijo Y, Kobayashi N et al (2003) POEMS syndrome caused refractory ascites in a polycystic disease patient undergoing hemodialysis. Clin Exp Nephrol 7:301–305
Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M et al (1998) Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow–Fukase (POEMS) syndrome. Muscle Nerve 21:1390–1397
Yamada Y, Sawai S, Misawa S, Kanai K, Shibuya K, Mori M et al (2013) Multiple angiogenetic factors are upregulated in POEMS syndrome. Ann Hematol 92:245–248
Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr (1972) Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 77:507–513
Nakazawa K, Itoh N, Shigematsu H, Koh CS (1992) An autopsy case of Crow–Fukase (POEMS) syndrome with a high level of IL-6 in the ascites. Special reference to glomerular lesions. Acta Pathol Jpn 42:651–656
Bocsi J, Hambsch J, Osmancik P, Schneider P, Valet G, Tarnok A (2002) Preoperative prediction of pediatric patients with effusions and edema following cardiopulmonary bypass surgery by serological and routine laboratory data. Crit Care 6:226–233
Dyck PJ, Engelstad J, Dispenzieri A (2006) Vascular endothelial growth factor and POEMS. Neurology 66:10–12
Scarlato M, Previtali SC (2011) POEMS syndrome: the matter-of-fact approach. Curr Opin Neurol 24:491–496
Gherardi RK, Bélec L, Fromont G, Divine M, Malapert D, Ganlard P et al (1994) Elevated levels of interleukin-1β (IL-1β) and IL-6 in serum and increased production of IL-1β mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome. Blood 83:2587–2593
D’Souza A, Hayman SR, Buadi F, Mauermann M, Lacy MQ, Gertz MA et al (2011) The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood 118:4663–4665
Mineta M, Hatori M, Sano H, Hosaka M, Kokubun S, Hiroki E et al (2006) Recurrent Crow–Fukase syndrome associated with increased serum levels of vascular endothelial growth factor: a case report and review of the literature. Tohoku J Exp Med 210:269–277
Scarlato M, Previtali SC, Carpo M, Pareyson D, Briani C, Del Bo R et al (2005) Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain 128(pt 8):1911–1920
Yamada Y, Sawai S, Misawa S, Kanai K, Shibuya K, Mori M et al (2013) Multiple angiogenetic factors are upregulated in POEMS syndrome. Ann Hematol 92:245–248
Chimenti MS, Ballanti E, Perricone C, Cipriani P, Giacomelli R, Perricone R (2013) Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways. Autoimmun Rev 12:599–606
Szczygiel AM, Brzezinka G, Targosz-Korecka M, Chlopicki S, Szymonski M (2012) Elasticity changes anti-correlate with NO production for human endothelial cells stimulated with TNF-α. Pflugers Arch 463:487–496
Nobile-Orazio E, Terenghi F, Giannotta C, Gallia F, Nozza A (2009) Serum VEGF levels in POEMS syndrome and immune-mediated neuropathies. Neurology 72:1024–1026
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cui, R.T., Yu, S.Y., Huang, X.S. et al. The characteristics of ascites in patients with POEMS syndrome. Ann Hematol 92, 1661–1664 (2013). https://doi.org/10.1007/s00277-013-1829-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-013-1829-7